Ledger.Open graph →
SEC Form D · filed April 3, 2018

Poseida Therapeutics, Inc

Offering
$30.5M
Sold
$30.5M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
San Diego, CA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (10)

Adrian Howd · San Diego, CADirectorEric Ostertag · LA JOLLA, CAExec · DirectorManinder F. Saluja · Luxembourg, LuxembourgExec · DirectorCarlos F. Heinene · Luxembourg, LuxembourgDirectorMark Gergen · San Diego, CAExec · DirectorDavid Hirsch · Pittsburgh, PADirectorJerrold Newman · NEW YORK, NYDirectorJames O'Mara · NEW YORK, NYExec · DirectorMark Gergen · San Diego, CAExec · DirectorDavid Hirsch · New York, NYDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗